BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27599383)

  • 21. Interception Targets of
    Tang SN; Jiang P; Kim S; Zhang J; Jiang C; Lü J
    Cancer Prev Res (Phila); 2021 Jun; 14(6):635-648. PubMed ID: 33648943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemopreventive Effects of Korean Angelica versus Its Major Pyranocoumarins on Two Lineages of Transgenic Adenocarcinoma of Mouse Prostate Carcinogenesis.
    Tang SN; Zhang J; Wu W; Jiang P; Puppala M; Zhang Y; Xing C; Kim SH; Jiang C; Lü J
    Cancer Prev Res (Phila); 2015 Sep; 8(9):835-44. PubMed ID: 26116406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rapid and Efficient Separation of Decursin and Decursinol Angelate from
    Kiyonga AN; An JH; Lee KY; Lim C; Suh YG; Chin YW; Jung K
    Molecules; 2019 Jun; 24(13):. PubMed ID: 31261662
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-tumor activities of decursinol angelate and decursin from Angelica gigas.
    Lee S; Lee YS; Jung SH; Shin KH; Kim BK; Kang SS
    Arch Pharm Res; 2003 Sep; 26(9):727-30. PubMed ID: 14560921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats.
    Park HS; Kim B; Oh JH; Kim YC; Lee YJ
    Planta Med; 2012 Jun; 78(9):909-13. PubMed ID: 22573368
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angelica gigas Nakai and Decursin Downregulate Myc Expression to Promote Cell Death in B-cell Lymphoma.
    Kim E; Nam J; Chang W; Zulfugarov IS; Okhlopkova ZM; Olennikov D; Chirikova NK; Kim SW
    Sci Rep; 2018 Jul; 8(1):10590. PubMed ID: 30002430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.
    Song JS; Chae JW; Lee KR; Lee BH; Choi EJ; Ahn SH; Kwon KI; Bae MA
    Xenobiotica; 2011 Oct; 41(10):895-902. PubMed ID: 21657833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decursin in Angelica gigas Nakai (AGN) Enhances Doxorubicin Chemosensitivity in NCI/ADR-RES Ovarian Cancer Cells via Inhibition of P-glycoprotein Expression.
    Choi HS; Cho SG; Kim MK; Kim MS; Moon SH; Kim IH; Ko SG
    Phytother Res; 2016 Dec; 30(12):2020-2026. PubMed ID: 27605402
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of Resveratrol-Loaded Herbal Extract-Based Nanocomposites and Their Application to the Therapy of Ovarian Cancer.
    Nam S; Lee SY; Kang WS; Cho HJ
    Nanomaterials (Basel); 2018 May; 8(6):. PubMed ID: 29857475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of
    Kweon B; Han YH; Kee JY; Mun JG; Jeon HD; Yoon DH; Choi BM; Hong SH
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32349276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 Isoforms in the Metabolism of Decursin and Decursinol Angelate from Korean Angelica.
    Zhang J; Li L; Tang S; Hale TW; Xing C; Jiang C; Lü J
    Am J Chin Med; 2015; 43(6):1211-30. PubMed ID: 26394652
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Improvement in antiproliferative activity of Angelica gigas Nakai by solid dispersion formation via hot-melt extrusion and induction of cell cycle arrest and apoptosis in HeLa cells.
    Jiang Y; Piao J; Cho HJ; Kang WS; Kim HY
    Biosci Biotechnol Biochem; 2015; 79(10):1635-43. PubMed ID: 26057458
    [TBL] [Abstract][Full Text] [Related]  

  • 33.
    Lü J; Jiang C; Schell TD; Joshi M; Raman JD; Xing C
    Am J Chin Med; 2022; 50(6):1475-1527. PubMed ID: 35876033
    [No Abstract]   [Full Text] [Related]  

  • 34. Therapeutic Effects of Decursin and
    Lee TK; Kang IJ; Sim H; Lee JC; Ahn JH; Kim DW; Park JH; Lee CH; Kim JD; Won MH; Choi SY
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33918660
    [No Abstract]   [Full Text] [Related]  

  • 35. Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.
    Choi KO; Lee I; Paik SY; Kim DE; Lim JD; Kang WS; Ko S
    J Med Food; 2012 Oct; 15(10):863-72. PubMed ID: 23039111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet anti-aggregatory effects of coumarins from the roots of Angelica genuflexa and A. gigas.
    Lee YY; Lee S; Jin JL; Yun-Choi HS
    Arch Pharm Res; 2003 Sep; 26(9):723-6. PubMed ID: 14560920
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional efficacy analysis of Angelica gigas Nakai on chicken myoblast cells through cell-based in vitro assay.
    Lee JH; Park JW; Seo ES; Kim HU; Kim SW; Han JS; Jun HS; Kim SJ; Park TS; Park BC
    Anim Sci J; 2019 Jul; 90(7):903-912. PubMed ID: 31012203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Chemoprevention with Korean Angelica: Active Compounds, Pharmacokinetics, and Human Translational Considerations.
    Lü J; Zhang J; Li L; Jiang C; Xing C
    Curr Pharmacol Rep; 2015 Dec; 1(6):373-381. PubMed ID: 26623248
    [No Abstract]   [Full Text] [Related]  

  • 39. Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells.
    Park IS; Kim B; Han Y; Yang H; Cho U; Kim SI; Kim JH; Yoon Park JH; Lee KW; Song YS
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31861646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Physicochemical characterization and toxicity of decursin and their derivatives from Angelica gigas.
    Mahat B; Chae JW; Baek IH; Song GY; Song JS; Cho SK; Kwon KI
    Biol Pharm Bull; 2012; 35(7):1084-90. PubMed ID: 22791156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.